Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
LetterLetter
Open Access

Induction immunochemotherapy followed by definitive radiotherapy in patients with limited-stage small cell lung cancer: a multicenter study

Junxu Wen, Qian Wang, Xinrui Yu, Yang Liu, Xiaoyan Yin, Shanshan Li, Heng Zhao, Zhaoqin Huang, Yu Chen and Xiangjiao Meng
Cancer Biology & Medicine May 2026, 20250800; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0800
Junxu Wen
1Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qian Wang
1Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xinrui Yu
1Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yang Liu
1Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaoyan Yin
1Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shanshan Li
2Department of Radiation Oncology, Zibo Municipal Hospital, Zibo 255400, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heng Zhao
3Department of Radiation Oncology, Affiliated Hospital of Jining Medical University, Jining 272029, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhaoqin Huang
4Department of Radiology, Shandong Provincial Hospital, Shandong First Medical University, Jinan 250021, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Zhaoqin Huang
  • For correspondence: devin813{at}163.com chenyu{at}sd-cancer.com mengxiangjiao{at}sina.com
Yu Chen
1Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yu Chen
  • For correspondence: devin813{at}163.com chenyu{at}sd-cancer.com mengxiangjiao{at}sina.com
Xiangjiao Meng
1Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Xiangjiao Meng
  • For correspondence: devin813{at}163.com chenyu{at}sd-cancer.com mengxiangjiao{at}sina.com
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Information

20250800
DOI 
https://doi.org/10.20892/j.issn.2095-3941.2025.0800

Published By 
Cancer Biology & Medicine
History 
  • Received December 22, 2025
  • Accepted April 7, 2026
  • Published online May 11, 2026.

Article Versions

  • You are currently viewing a previous version of this article (May 11, 2026 - 02:52).
  • View the most recent version of this article
Copyright & Usage 
Copyright: © 2026, The Authors This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License.

Author Information

Funding

  • National Natural Science Foundation of China

    82272845
  • Natural Science Foundation of Shandong

    ZR2023LZL001
  • Collaborative Academic Innovation Project of Shandong Cancer Hospital

    ZF003
  • Foundation of Shandong Provincial Medical Association

    YXH2024ZS007
  • Beijing Science and Technology Innovation Medical Development Foundation

    KC2023-JX-0288-PM97

The study was funded by the National Natural Science Foundation of China (82272845), Natural Science Foundation of Shandong (ZR2023LZL001), Collaborative Academic Innovation Project of Shandong Cancer Hospital (ZF003), Foundation of Shandong Provincial Medical Association (YXH2024ZS007), and Beijing Science and Technology Innovation Medical Development Foundation (KC2023-JX-0288-PM97).

PreviousNext
Back to top

In this issue

Cancer Biology & Medicine: 23 (6)
Cancer Biology & Medicine
Vol. 23, Issue 6
15 Jun 2026
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Induction immunochemotherapy followed by definitive radiotherapy in patients with limited-stage small cell lung cancer: a multicenter study
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
Induction immunochemotherapy followed by definitive radiotherapy in patients with limited-stage small cell lung cancer: a multicenter study
Junxu Wen, Qian Wang, Xinrui Yu, Yang Liu, Xiaoyan Yin, Shanshan Li, Heng Zhao, Zhaoqin Huang, Yu Chen, Xiangjiao Meng
Cancer Biology & Medicine May 2026, 20250800; DOI: 10.20892/j.issn.2095-3941.2025.0800

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Induction immunochemotherapy followed by definitive radiotherapy in patients with limited-stage small cell lung cancer: a multicenter study
Junxu Wen, Qian Wang, Xinrui Yu, Yang Liu, Xiaoyan Yin, Shanshan Li, Heng Zhao, Zhaoqin Huang, Yu Chen, Xiangjiao Meng
Cancer Biology & Medicine May 2026, 20250800; DOI: 10.20892/j.issn.2095-3941.2025.0800
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Patient characteristics
    • Efficacy
    • Safety
    • Exploratory subgroup efficacy and safety analysis
    • Determination of the optimal induction cycles
    • Supporting Information
    • Conflict of interest statement
    • Author contributions
    • Data availability statement
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Sequential nimotuzumab plus gemcitabine and nab-paclitaxel chemotherapy followed by irreversible electroporation in advanced pancreatic ductal adenocarcinoma: a retrospective real-world analysis
  • Unveiling molecular incomplete response (mIR) via ultra-deep NGS: a novel concept contrasting pathologic complete response (pCR) in occult lymph node micrometastases of non-small cell lung cancer
  • Ferumoxytol triggers cancer ferroptosis via an NF-κB-driven IRONKILL mechanism
Show more Letter

Similar Articles

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire